{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:40:38Z","timestamp":1792615238023,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP220K8873"],"award-info":[{"award-number":["JP220K8873"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,12,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, and chemoresistance poses a significant challenge in its treatment. Neutrophil extracellular traps (NETs) have emerged as key players in the tumour microenvironment, but their role in chemoresistance remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We investigated the involvement of NETs in PDAC chemoresistance using patient tumour samples, in vitro assays with gemcitabine (GEM)-treated PDAC cells, and in vivo mouse models. We evaluated cytokine production, NET formation and tumour response to GEM, with or without the CXCR1\/2 inhibitor navarixin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NETs are significantly accumulated in the tumours of PDAC patients exhibiting poor response to chemotherapy. GEM-treated PDAC cells secrete pro-inflammatory cytokines such as interleukin-8 (IL-8). IL-8 promote the formation of chemotherapy-induced NETs (chemoNETosis) through activation of CXCR 1\/2 on neutrophils. Importantly, treatment with navarixin significantly suppressed chemoNETosis, restored sensitivity to GEM, and significantly reduced tumour growth in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal that NETs contribute to chemoresistance in PDAC and that IL-8\u2013mediated chemoNETosis plays a pivotal role in this process. Inhibition of CXCR1\/2-mediated NET formation enhances the efficacy of GEM. This approach may represent a promising therapeutic strategy for overcoming chemoresistance in PDAC. These results support further clinical investigation of anti-NETs therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03192-1","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:59:10Z","timestamp":1758761950000},"page":"1640-1651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gemcitabine-induced neutrophil extracellular traps via interleukin-8-CXCR1\/2 pathway promote chemoresistance in pancreatic cancer"],"prefix":"10.1038","volume":"133","author":[{"given":"Shohei","family":"Nogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-8211","authenticated-orcid":false,"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuki","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomokazu","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosei","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4484-1253","authenticated-orcid":false,"given":"Shinji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Teraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-1050","authenticated-orcid":false,"given":"Hiroshi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"3192_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3192_CR2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164:752\u201365.","journal-title":"Gastroenterology"},{"key":"3192_CR3","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms20184504","volume":"20","author":"S Zeng","year":"2019","unstructured":"Zeng S, P\u00f6ttler M, Lan B, Gr\u00fctzmann R, Pilarsky C, Yang H. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20:4504.","journal-title":"Int J Mol Sci"},{"key":"3192_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"3192_CR5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21:938\u201345.","journal-title":"Nat Med"},{"key":"3192_CR6","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78921","volume":"11","author":"I Silva","year":"2022","unstructured":"Silva I, de C, Bianchi A, Deshpande NU, Sharma P, Mehra S, et al. Neutrophil-mediated fibroblast-tumor cell il-6\/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: a hybrid clinical-preclinical study. Elife. 2022;11:e78921.","journal-title":"Elife"},{"key":"3192_CR7","volume":"22","author":"P Murthy","year":"2023","unstructured":"Murthy P, Zenati MS, AlMasri SS, DeSilva A, Singhi AD, Paniccia A, et al. Impact of recombinant granulocyte colony-stimulating factor during neoadjuvant therapy on outcomes of resected pancreatic cancer. J Natl Compr Cancer Netw. 2023;22:e237070.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3192_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1136\/gutjnl-2017-313738","volume":"67","author":"TM Nywening","year":"2018","unstructured":"Nywening TM, Belt BA, Cullinan DR, Panni RZ, Han BJ, Sanford DE, et al. Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut. 2018;67:1112\u201323.","journal-title":"Gut"},{"key":"3192_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/j.gastro.2024.02.046","volume":"167","author":"Y Xie","year":"2024","unstructured":"Xie Y, Zhou T, Li X, Zhao K, Bai W, Hou X, et al. Targeting ESE3\/EHF with nifurtimox inhibits CXCR2+ neutrophil infiltration and overcomes pancreatic cancer resistance to chemotherapy and immunotherapy. Gastroenterology. 2024;167:281\u201397.","journal-title":"Gastroenterology"},{"key":"3192_CR10","first-page":"6176","volume":"13","author":"R Sturgeon","year":"2023","unstructured":"Sturgeon R, Goel P, Singh RK. Tumor-associated neutrophils in pancreatic cancer progression and metastasis. Am J Cancer Res. 2023;13:6176\u201389.","journal-title":"Am J Cancer Res"},{"key":"3192_CR11","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/cancers14051359","volume":"14","author":"MH Shahzad","year":"2022","unstructured":"Shahzad MH, Feng L, Su X, Brassard A, Dhoparee-Doomah I, Ferri LE, et al. Neutrophil extracellular traps in cancer therapy resistance. Cancers. 2022;14:1359.","journal-title":"Cancers"},{"key":"3192_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccell.2023.02.001","volume":"41","author":"JM Adrover","year":"2023","unstructured":"Adrover JM, McDowell SAC, He X-Y, Quail DF, Egeblad M. NETworking with cancer: the bidirectional interplay between cancer and neutrophil extracellular traps. Cancer Cell. 2023;41:505\u201326.","journal-title":"Cancer Cell"},{"key":"3192_CR13","first-page":"1532","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (1979). 2004;303:1532\u20135.","journal-title":"Science (1979)"},{"key":"3192_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.10.015","volume":"497","author":"H Kajioka","year":"2021","unstructured":"Kajioka H, Kagawa S, Ito A, Yoshimoto M, Sakamoto S, Kikuchi S, et al. Targeting neutrophil extracellular traps with thrombomodulin prevents pancreatic cancer metastasis. Cancer Lett. 2021;497:1\u201313.","journal-title":"Cancer Lett"},{"key":"3192_CR15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.immuni.2020.03.001","volume":"52","author":"\u00c1 Teijeira","year":"2020","unstructured":"Teijeira \u00c1, Garasa S, Gato M, Alfaro C, Migueliz I, Cirella A, et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity. 2020;52:856\u2013871.e8.","journal-title":"Immunity"},{"key":"3192_CR16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190354","volume":"217","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chandra V, Sanchez ER, Dutta P, Quesada PR, Rakoski A, et al. Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med. 2020;217:e20190354.","journal-title":"J Exp Med"},{"key":"3192_CR17","doi-asserted-by":"publisher","first-page":"5333","DOI":"10.3390\/cancers13215333","volume":"13","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wang Y, Onuma A, He J, Wang H, Xia Y, et al. Neutrophils extracellular traps inhibition improves pd-1 blockade immunotherapy in colorectal cancer. Cancers. 2021;13:5333.","journal-title":"Cancers"},{"key":"3192_CR18","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.2147\/JIR.S441981","volume":"16","author":"W Zhong","year":"2023","unstructured":"Zhong W, Wang Q, Shen X, Lv Y, Sun L, An R, et al. Neutrophil extracellular trap is surrogate biomarker for prognosis and response to neoadjuvant therapy in locally advanced rectal cancer. J Inflamm Res. 2023;16:6443\u201355.","journal-title":"J Inflamm Res"},{"key":"3192_CR19","doi-asserted-by":"publisher","first-page":"21807","DOI":"10.1002\/cam4.6748","volume":"12","author":"R Xie","year":"2023","unstructured":"Xie R, Shang B, Shi H, Bi X, Song Y, Qu W, et al. Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Med. 2023;12:21807\u201319.","journal-title":"Cancer Med"},{"key":"3192_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","volume":"41","author":"A Mousset","year":"2023","unstructured":"Mousset A, Lecorgne E, Bourget I, Lopez P, Jenovai K, Cherfils-Vicini J, et al. Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation. Cancer Cell. 2023;41:757\u2013775.e10.","journal-title":"Cancer Cell"},{"key":"3192_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00262-022-03334-x","volume":"72","author":"Y Kajiwara","year":"2023","unstructured":"Kajiwara Y, Tazawa H, Yamada M, Kanaya N, Fushimi T, Kikuchi S, et al. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer. Cancer Immunol Immunother. 2023;72:1285\u2013300.","journal-title":"Cancer Immunol Immunother"},{"key":"3192_CR22","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","volume":"127","author":"DB Evans","year":"1992","unstructured":"Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335\u20139.","journal-title":"Arch Surg"},{"key":"3192_CR23","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/path.5753","volume":"255","author":"CE de Andrea","year":"2021","unstructured":"de Andrea CE, Ochoa MC, Villalba-Esparza M, Teijeira \u00c1, Schalper KA, Abengozar-Muela M, et al. Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8. J Pathol. 2021;255:190\u2013201.","journal-title":"J Pathol"},{"key":"3192_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155828","volume":"153","author":"K Matsushima","year":"2022","unstructured":"Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: an evolving chemokine. Cytokine. 2022;153:155828.","journal-title":"Cytokine"},{"key":"3192_CR25","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1021\/jm0609622","volume":"49","author":"MP Dwyer","year":"2006","unstructured":"Dwyer MP, Yu Y, Chao J, Aki C, Chao J, Biju P, et al.Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl) propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): a potent, orally bioavailable CXCR2\/CXCR1 receptor antagonist.J Med Chem.2006;49:7603\u20136.","journal-title":"J Med Chem."},{"key":"3192_CR26","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4161\/cc.6.18.4728","volume":"6","author":"KE Ewings","year":"2007","unstructured":"Ewings KE, Wiggins CM, Cook SJ. Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle. 2007;6:2236\u201340.","journal-title":"Cell Cycle"},{"key":"3192_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00463-y","volume":"11","author":"B Shang","year":"2023","unstructured":"Shang B, Cui H, Xie R, Wu J, Shi H, Bi X, et al. Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target. Biomark Res. 2023;11:24.","journal-title":"Biomark Res"},{"key":"3192_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1089\/10799900050198372","volume":"20","author":"X Le","year":"2000","unstructured":"Le X, Shi Q, Wang B, Xiong Q, Qian C, Peng Z, et al. Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma. J Interferon Cytokine Res. 2000;20:935\u201346.","journal-title":"J Interferon Cytokine Res"},{"key":"3192_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215864","volume":"548","author":"L Wu","year":"2022","unstructured":"Wu L, Ge Y, Yuan Y, Li H, Sun H, Xu C, et al. Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma. Cancer Lett. 2022;548:215864.","journal-title":"Cancer Lett"},{"key":"3192_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","volume":"382","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Duan Q, Zhao H, Liu T, Wu H, Shen Q, et al. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox\/ROS\/NF-\u03baB\/STAT3 signaling cascade. Cancer Lett. 2016;382:53\u201363.","journal-title":"Cancer Lett"},{"key":"3192_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbamcr.2007.05.002","volume":"1773","author":"M Donadelli","year":"2007","unstructured":"Donadelli M, Costanzo C, Beghelli S, Scupoli MT, Dandrea M, Bonora A, et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim Biophys Acta Mol Cell Res. 2007;1773:1095\u2013106.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3192_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI178344","volume":"134","author":"A Mousset","year":"2024","unstructured":"Mousset A, Albrengues J. NETs unleashed: neutrophil extracellular traps boost chemotherapy against colorectal cancer. J Clin Investig. 2024;134:e178344.","journal-title":"J Clin Investig"},{"key":"3192_CR33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/cancers12020505","volume":"12","author":"B Muqaku","year":"2020","unstructured":"Muqaku B, Pils D, Mader JC, Aust S, Mangold A, Muqaku L, et al. Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer. Cancers. 2020;12:505.","journal-title":"Cancers"},{"key":"3192_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/pcmr.12818","volume":"33","author":"F Schedel","year":"2020","unstructured":"Schedel F, Mayer-Hain S, Pappelbaum KI, Metze D, Stock M, Goerge T, et al. Evidence and impact of neutrophil extracellular traps in malignant melanoma. Pigment Cell Melanoma Res. 2020;33:63\u201373.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3192_CR35","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/cancers14071681","volume":"14","author":"AC Pe\u00f1a-Romero","year":"2022","unstructured":"Pe\u00f1a-Romero AC, Orenes-Pi\u00f1ero E. Dual effect of immune cells within tumour microenvironment: pro-and anti-tumour effects and their triggers. Cancers. 2022;14:1681.","journal-title":"Cancers"},{"key":"3192_CR36","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/ijc.30635","volume":"140","author":"S Najmeh","year":"2017","unstructured":"Najmeh S, Cools-Lartigue J, Rayes RF, Gowing S, Vourtzoumis P, Bourdeau F, et al. Neutrophil extracellular traps sequester circulating tumor cells via \u03b21-integrin mediated interactions. Int J Cancer. 2017;140:2321\u201330.","journal-title":"Int J Cancer"},{"key":"3192_CR37","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1172\/JCI67484","volume":"123","author":"J Cools-Lartigue","year":"2013","unstructured":"Cools-Lartigue J, Spicer J, McDonald B, Gowing S, Chow S, Giannias B, et al. Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. J Clin Investig. 2013;123:3446\u201358.","journal-title":"J Clin Investig"},{"key":"3192_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41586-020-2394-6","volume":"583","author":"L Yang","year":"2020","unstructured":"Yang L, Liu Q, Zhang X, Liu X, Zhou B, Chen J, et al. DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 2020;583:133\u20138.","journal-title":"Nature"},{"key":"3192_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101799","volume":"23","author":"E Deryugina","year":"2020","unstructured":"Deryugina E, Carr\u00e9 A, Ardi V, Muramatsu T, Schmidt J, Pham C, et al. Neutrophil elastase facilitates tumor cell intravasation and early metastatic events. iScience. 2020;23:101799.","journal-title":"iScience"},{"key":"3192_CR40","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1002\/eji.201242628","volume":"42","author":"MM Gaida","year":"2012","unstructured":"Gaida MM, Steffen TG, G\u00fcnther F, Tschaharganeh DF, Felix K, Bergmann F, et al. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors. Eur J Immunol. 2012;42:3369\u201380.","journal-title":"Eur J Immunol"},{"key":"3192_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361:eaao4227.","journal-title":"Science"},{"key":"3192_CR42","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/0008-5472.CAN-19-0800","volume":"79","author":"HO Yazdani","year":"2019","unstructured":"Yazdani HO, Roy E, Comerci AJ, Van Der Windt DJ, Zhang H, Huang H, et al. Translational science Neutrophil extracellular traps drive mitochondrial homeostasis in tumors to augment growth. Cancer Res. 2019;79:5626\u201339.","journal-title":"Cancer Res"},{"key":"3192_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2147\/JHC.S303588","volume":"8","author":"X Guan","year":"2021","unstructured":"Guan X, Lu Y, Zhu H, Yu S, Zhao W, Chi X, et al. The Crosstalk between cancer cells and neutrophils enhances hepatocellular carcinoma metastasis via neutrophil extracellular traps-associated cathepsin G component: a potential therapeutic target. J Hepatocell Carcinoma. 2021;8:451\u201365.","journal-title":"J Hepatocell Carcinoma"},{"key":"3192_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785222","volume":"12","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier C, Yazdani HO, Morder K, Geller DA, Simmons RL, Tohme S. Neutrophil extracellular traps promote T cell exhaustion in the tumor microenvironment. Front Immunol. 2021;12:785222.","journal-title":"Front Immunol"},{"key":"3192_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","volume":"13","author":"LY Yang","year":"2020","unstructured":"Yang LY, Luo Q, Lu L, Zhu WW, Sun HT, Wei R, et al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020;13:3.","journal-title":"J Hematol Oncol"},{"key":"3192_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7673","volume":"6","author":"E Kolaczkowska","year":"2015","unstructured":"Kolaczkowska E, Jenne CN, Surewaard BGJ, Thanabalasuriar A, Lee WY, Sanz MJ, et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat Commun. 2015;6:6673.","journal-title":"Nat Commun"},{"key":"3192_CR47","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","volume":"29","author":"CW Steele","year":"2016","unstructured":"Steele CW, Karim SA, Leach JDG, Bailey P, Upstill-Goddard R, Rishi L, et al. CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell. 2016;29:832\u201345.","journal-title":"Cancer Cell"},{"key":"3192_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10637-023-01410-2","volume":"42","author":"AJ Armstrong","year":"2024","unstructured":"Armstrong AJ, Geva R, Chung HC, Lemech C, Miller WH, Hansen AR, et al. CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial. Investig New Drugs. 2024;42:145\u201359.","journal-title":"Investig New Drugs"},{"key":"3192_CR49","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124.","journal-title":"J Natl Cancer Inst"},{"key":"3192_CR50","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fonc.2020.01036","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Hu Y, Ma C, Sun H, Wei X, Li M, et al. Diagnostic, therapeutic predictive, and prognostic value of neutrophil extracellular traps in patients with gastric adenocarcinoma. Front Oncol. 2020;10:1036.","journal-title":"Front Oncol"},{"key":"3192_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.128008","volume":"5","author":"RF Rayes","year":"2019","unstructured":"Rayes RF, Mouhanna JG, Nicolau I, Bourdeau F, Giannias B, Rousseau S, et al. Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects. JCI Insight. 2019;5:e128008.","journal-title":"JCI Insight"},{"key":"3192_CR52","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/rccm.201405-0992OC","volume":"191","author":"SI Rennard","year":"2015","unstructured":"Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, et al. CXCR2 antagonist MK-7123 a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191:1001\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"3192_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fphys.2014.00141","volume":"5","author":"JA McCarroll","year":"2014","unstructured":"McCarroll JA, Naim S, Sharbeen G, Russia N, Lee J, Kavallaris M, et al. Role of pancreatic stellate cells in chemoresistance in pancreatic cancer. Front Physiol. 2014;5:141.","journal-title":"Front Physiol"},{"key":"3192_CR54","doi-asserted-by":"publisher","first-page":"e1605822","DOI":"10.1080\/2162402X.2019.1605822","volume":"8","author":"JL Miller-Ocuin","year":"2019","unstructured":"Miller-Ocuin JL, Liang X, Boone BA, Doerfler WR, Singhi AD, Tang D, et al. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology. 2019;8:e1605822.","journal-title":"Oncoimmunology"},{"key":"3192_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216260","volume":"567","author":"M Yoshimoto","year":"2023","unstructured":"Yoshimoto M, Kagawa S, Kajioka H, Taniguchi A, Kuroda S, Kikuchi S, et al. Dual antiplatelet therapy inhibits neutrophil extracellular traps to reduce liver micrometastases of intrahepatic cholangiocarcinoma. Cancer Lett. 2023;567:216260.","journal-title":"Cancer Lett"},{"key":"3192_CR56","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","volume":"75","author":"H Wang","year":"2021","unstructured":"Wang H, Zhang H, Wang Y, Brown ZJ, Xia Y, Huang Z, et al. Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis. J Hepatol. 2021;75:1271\u201383.","journal-title":"J Hepatol"},{"key":"3192_CR57","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s43018-021-00194-9","volume":"2","author":"SAC McDowell","year":"2021","unstructured":"McDowell SAC, Luo RBE, Arabzadeh A, Dor\u00e9 S, Bennett NC, Breton V, et al. Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration. Nat Cancer. 2021;2:545\u201362.","journal-title":"Nat Cancer"},{"key":"3192_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217288","volume":"605","author":"Y Ning","year":"2024","unstructured":"Ning Y, Chen Y, Tian T, Gao X, Liu X, Wang J, et al. S100A7 orchestrates neutrophil chemotaxis and drives neutrophil extracellular traps (NETs) formation to facilitate lymph node metastasis in cervical cancer patients. Cancer Lett. 2024;605:217288.","journal-title":"Cancer Lett"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03192-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03192-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:18:30Z","timestamp":1764181110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03192-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,12,14]]}},"alternative-id":["3192"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03192-1","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study using clinical samples from patients with pancreatic cancer was approved by the Institutional Review Board of Okayama University (No. 2406-025) and was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived owing to the retrospective nature of the study, and information regarding the study was disclosed to patients with the opportunity to opt out. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Okayama University. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"During the preparation of this work the authors used OpenAI\u2019s ChatGPT for language refinement and assistance in editing the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}]}}